Literature DB >> 22857982

Late outcomes in patients undergoing aortopulmonary window for pulmonary atresia/stenosis and major aortopulmonary collaterals.

Richard D Mainwaring1, V Mohan Reddy, Stanton B Perry, Lynn Peng, Frank L Hanley.   

Abstract

BACKGROUND: Pulmonary atresia with ventricular septal defect (PA/VSD) and major aortopulmonary collateral arteries (MAPCAs) is a complex form of congenital heart defect. One identifiable subset has small (<2.5 mm) intrapericardial branch pulmonary arteries that are (1) confluent, (2) have normal arborization, and (3) have dual-supplied collateral vessels. When this anatomy is associated with limited pulmonary blood flow, the patients are candidates for creation of an aortopulmonary window to stimulate growth of the pulmonary arteries. The purpose of this study was to review our experience with creation of an aortopulmonary window as the initial palliative procedure.
METHODS: This was a retrospective review of our surgical experience with 35 children undergoing aortopulmonary window creation from 2002 to 2011. Patients were identified by preoperative cardiac catheterization to define the cardiac and pulmonary artery anatomy.
RESULTS: There was no mortality in 35 patients undergoing aortopulmonary window creation. These patients have subsequently undergone 78 cardiac procedures (with 2 operative mortalities). Eighteen of these patients have achieved complete repair, 4 patients in a second procedure, 6 patients in a third procedure, 5 patients in a fourth procedure, and 3 patients in a fifth procedure.
CONCLUSIONS: The data demonstrate that patients can undergo creation of an aortopulmonary window with excellent early results. Few patients were amenable to complete repair at the second operation, and most required multiple reoperations to recruit sufficient arborization. We interpret these counterintuitive results to suggest that hypoplastic central pulmonary arteries and diminished pulmonary blood flow are markers for a less well developed pulmonary vascular bed.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22857982     DOI: 10.1016/j.athoracsur.2012.03.061

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Midline unifocalization for pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries.

Authors:  Richard D Mainwaring
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

2.  Anesthetic management in tetralogy of fallot with pulmonary atresia and major aortopulmonary collateral arteries in pediatric patients: One year experience.

Authors:  Ahmad Abuzaid; Ibrahim Abd Elaal; Ahmed Abdulaziz; Rawan Abuzaid
Journal:  Saudi J Anaesth       Date:  2020-03-05

3.  Staged correction of pulmonary atresia, ventricular septal defect, and collateral arteries.

Authors:  Pieter van de Woestijne; Mostafa Mokhles; Ingrid van Beynum; Peter de Jong; Jeroen Wilschut; Ad Bogers
Journal:  J Card Surg       Date:  2022-02-09       Impact factor: 1.778

4.  Verifying the Usefulness of Pulmonary Blood Flow Studies in the Correction of Pulmonary Atresia and Ventricular Septal Defect with Major Aortopulmonary Collateral Arteries.

Authors:  Zirou Huang; Fan Cao; Rongjun Zou; Minghui Zou; Weidan Chen; Wenlei Li; Guodong Huang; Li Ma; Xinxin Chen
Journal:  Cardiol Res Pract       Date:  2021-07-24       Impact factor: 1.866

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.